This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
Atrialfibrillation, or AFib, is a fast and irregular heartrhythm that, left untreated, can lead to bloodclots, stroke and heart failure. It's the most common type of arrhythmia, a potentially serious condition in which the heart beats too quickly, too slowly or in an irregular pattern.
Ioannis Katsoularis, image courtesy of Klas Sjöberg milla1cf Thu, 12/14/2023 - 09:23 December 14, 2023 — Individuals infected with COVID-19 are also at an increased risk of suffering from heartrhythm disturbances, such as atrialfibrillation.
Outcomes of ablation with the FARAPULSE PFA System – a nonthermal treatment in which electric fields selectively ablate heart tissue – will be compared to outcomes following use of anti-arrhythmic drug (AAD) therapy, which is commonly prescribed for patients living with persistent AF. Circulation.
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. Our mission to combat complex heartrhythm diseases relies on optimizing interoperability.
Atrialfibrillation often shortened to AFib is an irregular and often rapid heartrhythm that can lead to serious health complications. AFib occurs when the electrical signals in the upper chambers of your heart (the atria) become chaotic, causing the chambers to quiver instead of beating effectively.
milla1cf Wed, 12/13/2023 - 10:24 December 13, 2023 — A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrialfibrillation (or AFib)—an irregular, fast heartbeat that is associated with stroke and heart failure.
AFib (short for atrialfibrillation), a common heartrhythm disorder in adults, can have disastrous consequences, including life-threatening bloodclots and stroke if left undetected or untreated.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrialfibrillation (AFib).
Antiarrhythmic Drugs WHAT THEY DO : Antiarrhythmic drugs are used to help prevent or treat abnormal heartrhythms, such as atrialfibrillation and ventricular tachycardia. The most common antiarrhythmic drugs for children with congenital heart disease (CHD) include beta-blockers (see above) and sodium channel blockers.
Atrialfibrillation is the most common heartrhythm disorder in adults, affecting more than 5 million people in the U.S., according to the American Heart Association. The most frequent cardiac arrhythmia, atrialfibrillation, is known to independently increase the risk of dementia, said Massimo Barbagallo, M.D.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content